Literature DB >> 25008366

Modern management of atrial fibrillation requires initial identification of "low-risk" patients using the CHA2DS2-VASc score, and not focusing on "high-risk" prediction.

Gregory Yh Lip1, Deirdre A Lane.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25008366     DOI： 10.1253/circj.cj-14-0584

Source DB:  PubMed          Journal:  Circ J        ISSN： 1346-9843            Impact factor:   2.993


× No keyword cloud information.
  9 in total

1.  Stroke prevention in atrial fibrillation: Where are we now?

Authors:  Gregory Y H Lip
Journal:  Indian Heart J       Date:  2015-11-28

Review 2.  Atrial Fibrillation in the ICU.

Authors:  Nicholas A Bosch; Jonathan Cimini; Allan J Walkey
Journal:  Chest       Date:  2018-04-06       Impact factor: 9.410

Review 3.  Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.

Authors:  Shadi Yaghi; Hooman Kamel
Journal:  Stroke       Date:  2017-09-15       Impact factor: 7.914

Review 4.  Optimizing atrial fibrillation management: from ICU and beyond.

Authors:  Allan J Walkey; D Kyle Hogarth; Gregory Y H Lip
Journal:  Chest       Date:  2015-10       Impact factor: 9.410

5.  Individualising Anticoagulant Therapy in Atrial Fibrillation Patients.

Authors:  Marco Alings
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

6.  New combined risk score to predict atrial fibrillation after cardiac surgery: COM-AF.

Authors:  Lucrecia M Burgos; Andreína Gil Ramírez; Leonardo Seoane; Juan F Furmento; Juan P Costabel; Mirta Diez; Daniel Navia
Journal:  Ann Card Anaesth       Date:  2021 Oct-Dec

7.  CHA2DS2-VASc score stratifies mortality risk in heart failure patients aged 75 years and older with and without atrial fibrillation.

Authors:  Andrea Sonaglioni; Chiara Lonati; Elisabetta Rigamonti; Mauro Viganò; Gian Luigi Nicolosi; Marco Proietti; Michele Lombardo; Sergio Harari
Journal:  Aging Clin Exp Res       Date:  2022-03-16       Impact factor: 3.636

Review 8.  Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.

Authors:  Hans-Christoph Diener; James Aisenberg; Jack Ansell; Dan Atar; Günter Breithardt; John Eikelboom; Michael D Ezekowitz; Christopher B Granger; Jonathan L Halperin; Stefan H Hohnloser; Elaine M Hylek; Paulus Kirchhof; Deirdre A Lane; Freek W A Verheugt; Roland Veltkamp; Gregory Y H Lip
Journal:  Eur Heart J       Date:  2017-03-21       Impact factor: 29.983

9.  Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.

Authors:  William F McIntyre; David Conen; Brian Olshansky; Jonathan L Halperin; Emil Hayek; Menno V Huisman; Gregory Y H Lip; Shihai Lu; Jeff S Healey
Journal:  Clin Cardiol       Date:  2018-05-10       Impact factor: 2.882
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.